AIM ImmunoTech Inc. — Director's Dealing 2025

Feb 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2025-02-14

Reporting Person: MITCHELL WILLIAM M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-14	Common Stock	A	43330	$0.1202	Disposed	241393	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	190	Indirect
Common Stock	190	Indirect

Footnotes

F1: These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan.